The EVO ICL for Moderate Myopia: Results from the US FDA Clinical Trial

The EVO ICL for Moderate Myopia: Results from the US FDA Clinical Trial

Mark Packer Packer Research Associates, Boulder, CO, USACorrespondence: Mark Packer, Packer Research Associates, 1400 Bluebell Ave, Boulder, CO, 80302, USA, Tel +1 541 915 – 0291, Email mark@markpackerconsulting.comPurpose: To evaluate the safety and effectiveness of collamer posterior chamber phaki...

Full description

Bibliographic Details
Main Author: Packer M
Format: Article
Language:English
Published: Dove Medical Press 2022-12-01
Series:Clinical Ophthalmology
Subjects:
phakic refractive lens
moderate myopia
astigmatism
implantable collamer lens
Online Access:https://www.dovepress.com/the-evo-icl-for-moderate-myopia-results-from-the-us-fda-clinical-trial-peer-reviewed-fulltext-article-OPTH

Internet

https://www.dovepress.com/the-evo-icl-for-moderate-myopia-results-from-the-us-fda-clinical-trial-peer-reviewed-fulltext-article-OPTH

Similar Items